J-code: Drugs administered other than oral method; chemotherapy drugs Drugs administered other than oral method; chemotherapy drugs
1,255 codes
Billing context
J-codes are permanent national codes for drugs and biologicals — most often clinician-administered (buy-and-bill) products paid under Medicare Part B — plus certain immunosuppressive, inhalation (via DME), and oral anticancer/antiemetic drugs. Units are reported in multiples of the dosage in the code descriptor.
| Code | Long descriptor | Payment limit (Q4 2026) | Added | Status |
|---|---|---|---|---|
| J0013 | Esketamine, nasal spray, 1 mg | — | Jan 1, 2026 | Active |
| J0014 | Cocaine hydrochloride nasal solution (goprelto), 1 mg | $1.825per 1 MG | Oct 1, 2026 | Active |
| J0120 | Injection, tetracycline, up to 250 mg | — | Jan 1, 1986 | Active |
| J0121 | Injection, omadacycline, 1 mg | $4.293per 1 MG | Oct 1, 2019 | Active |
| J0122 | Injection, eravacycline, 1 mg | $1.333per 1 MG | Oct 1, 2019 | Active |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | $45.937per 10 MG | Jan 1, 2007 | Active |
| J0130 | Injection abciximab, 10 mg | — | Jan 1, 1999 | Active |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | $0.044per 10 MG | Jan 1, 2012 | Active |
| J0132 | Injection, acetylcysteine, 100 mg | $0.499per 100 MG | Jan 1, 2006 | Active |
| J0133 | Injection, acyclovir, 5 mg | $0.048per 5 MG | Jan 1, 2006 | Active |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | $0.051per 10 MG | Jan 1, 2023 | Active |
| J0135 | Injection, adalimumab, 20 mg | — | Jan 1, 2005 | Ended Dec 31, 2024 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | $0.046per 10 MG | Jan 1, 2023 | Active |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | $0.048per 10 MG | Jul 1, 2023 | Active |
| J0138 | Injection, acetaminophen 10 mg and ibuprofen 3 mg | $0.129per 10 MG/3MG | Oct 1, 2024 | Active |
| J0139 | Injection, adalimumab, 1 mg | — | Jan 1, 2025 | Active |
| J0150 | Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | — | Jan 1, 1994 | Ended Dec 31, 2014 |
| J0151 | Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) | — | Jan 1, 2014 | Ended Dec 31, 2014 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | $0.378per 1 MG | Jan 1, 2015 | Active |
| J0162 | Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg | $0.321per 0.1 MG | Jan 1, 2026 | Active |
| J0163 | Injection, epinephrine in sodium chloride (endo), 0.1 mg | $0.710per 0.1 MG | Oct 1, 2025 | Active |
| J0164 | Injection, epinephrine in sodium chloride (baxter), 0.1 mg | $0.912per 0.1 MG | Oct 1, 2025 | Active |
| J0165 | Injection, epinephrine, not otherwise specified, 0.1 mgNOC / NOS | $0.206per 0.1 MG | Jul 1, 2025 | Active |
| J0166 | Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg | $0.830per 0.1 MG | Jul 1, 2025 | Active |
| J0167 | Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg | $1.422per 0.1 MG | Jul 1, 2025 | Active |
| J0168 | Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg | $2.697per 0.1 MG | Jul 1, 2025 | Active |
| J0169 | Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg | $0.869per 0.1 MG | Jul 1, 2025 | Active |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | — | Jan 1, 2011 | Ended Jun 30, 2025 |
| J0172 | Injection, aducanumab-avwa, 2 mg | — | Jan 1, 2022 | Ended Dec 31, 2025 |
| J0173 | Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg | — | Jan 1, 2023 | Ended Jun 30, 2025 |
| J0174 | Lecanemab-irmb, for intravenous injection, 1 mg | $1.361per 1 MG | Jul 6, 2023 | Active |
| J0175 | Injection, donanemab-azbt, 2 mg | $4.185per 2 MG | Jul 2, 2024 | Active |
| J0177 | Injection, aflibercept hd, 1 mg | $290.902per 1 MG | Apr 1, 2024 | Active |
| J0178 | Injection, aflibercept, 1 mg | $722.251per 1 MG | Jan 1, 2013 | Active |
| J0179 | Injection, brolucizumab-dbll, 1 mg | $360.439per 1 MG | Jan 1, 2020 | Active |
| J0180 | Injection, agalsidase beta, 1 mg | $230.540per 1 MG | Jan 1, 2005 | Active |
| J0184 | Injection, amisulpride, 1 mg | — | Jan 1, 2024 | Active |
| J0185 | Injection, aprepitant, 1 mg | $1.624per 1 MG | Jan 1, 2019 | Active |
| J0190 | Injection, biperiden lactate, per 5 mg | — | Jan 1, 1982 | Ended Dec 31, 2025 |
| J0200 | Injection, alatrofloxacin mesylate, 100 mg | — | Jan 1, 2000 | Ended Dec 31, 2025 |
| J0202 | Injection, alemtuzumab, 1 mg | $2,506.200per 1 MG | Jan 1, 2016 | Active |
| J0205 | Injection, alglucerase, per 10 units | — | Jan 1, 1993 | Ended Dec 31, 2025 |
| J0206 | Injection, allopurinol sodium, 1 mg | $4.292per 1 MG | Jul 1, 2023 | Active |
| J0207 | Injection, amifostine, 500 mg | — | Jan 1, 1998 | Active |
| J0208 | Injection, sodium thiosulfate (pedmark), 100 mg | — | Apr 1, 2023 | Active |
| J0209 | Injection, sodium thiosulfate (hope), 100 mg | — | Apr 1, 2024 | Active |
| J0210 | Injection, methyldopate hcl, up to 250 mg | — | Jan 1, 1984 | Active |
| J0211 | Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote) | — | Jul 1, 2024 | Active |
| J0215 | Injection, alefacept, 0.5 mg | — | Jan 1, 2004 | Ended Dec 31, 2025 |
| J0216 | Injection, alfentanil hydrochloride, 500 micrograms | — | Jul 1, 2023 | Active |
| J0217 | Injection, velmanase alfa-tycv, 1 mg | $479.191per 1 MG | Jan 1, 2024 | Active |
| J0218 | Injection, olipudase alfa-rpcp, 1 mg | $404.784per 1 MG | Apr 1, 2023 | Active |
| J0219 | Injection, avalglucosidase alfa-ngpt, 4 mg | $83.816per 4 MG | Apr 1, 2022 | Active |
| J0220 | Injection, alglucosidase alfa, 10 mg, not otherwise specifiedNOC / NOS | — | Jan 1, 2008 | Active |
| J0221 | Injection, alglucosidase alfa, (lumizyme), 10 mg | $211.056per 10 MG | Jan 1, 2012 | Active |
| J0222 | Injection, patisiran, 0.1 mg | $101.181per 0.1 MG | Oct 1, 2019 | Active |
| J0223 | Injection, givosiran, 0.5 mg | $120.744per 0.5 MG | Jul 1, 2020 | Active |
| J0224 | Injection, lumasiran, 0.5 mg | $336.640per 0.5 MG | Jul 1, 2021 | Active |
| J0225 | Injection, vutrisiran, 1 mg | $5,008.939per 1 MG | Jan 1, 2023 | Active |
| J0248 | Injection, remdesivir, 1 mg | $7.511per 1 MG | Dec 23, 2021 | Active |
| J0256 | Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mgNOC / NOS | $5.077per 10 MG | Jan 1, 1989 | Active |
| J0257 | Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg | $5.640per 10 MG | Jan 1, 2012 | Active |
| J0270 | Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | — | Jan 1, 1997 | Active |
| J0275 | Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | — | Jan 1, 1999 | Active |
| J0278 | Injection, amikacin sulfate, 100 mg | $0.612per 100 MG | Jan 1, 2006 | Active |
| J0280 | Injection, aminophyllin, up to 250 mg | $10.757per 250 MG | Jan 1, 1984 | Active |
| J0281 | Injection, aminocaproic acid, 1 gram | $1.738per 1 GM | Apr 1, 2025 | Active |
| J0282 | Injection, amiodarone hydrochloride, 30 mg | $0.384per 30 MG | Jan 1, 2001 | Active |
| J0283 | Injection, amiodarone hydrochloride (nexterone), 30 mg | $2.763per 30 MG | Jan 1, 2023 | Active |
| J0285 | Injection, amphotericin b, 50 mg | $42.474per 50 MG | Jan 1, 1999 | Active |
| J0287 | Injection, amphotericin b lipid complex, 10 mg | — | Jan 1, 2003 | Active |
| J0288 | Injection, amphotericin b cholesteryl sulfate complex, 10 mg | — | Jan 1, 2003 | Ended Dec 31, 2025 |
| J0289 | Injection, amphotericin b liposome, 10 mg | $17.851per 10 MG | Jan 1, 2003 | Active |
| J0290 | Injection, ampicillin sodium, 500 mg | $0.619per 500 MG | Jan 1, 1984 | Active |
| J0291 | Injection, plazomicin, 5 mg | $3.519per 5 MG | Oct 1, 2019 | Active |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | $1.457per 1.5 GM | Jan 1, 1995 | Active |
| J0300 | Injection, amobarbital, up to 125 mg | — | Jan 1, 1982 | Active |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | — | Jan 1, 1986 | Active |
| J0348 | Injection, anidulafungin, 1 mg | $0.452per 1 MG | Jan 1, 2007 | Active |
| J0349 | Injection, rezafungin, 1 mg | $11.182per 1 MG | Oct 1, 2023 | Active |
| J0350 | Injection, anistreplase, per 30 units | — | Jan 1, 1986 | Ended Dec 31, 2025 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | $3.344per 20 MG | Jan 1, 1986 | Active |
| J0364 | Injection, apomorphine hydrochloride, 1 mg | — | Jan 1, 2007 | Active |
| J0365 | Injection, aprotonin, 10,000 kiu | — | Jan 1, 2006 | Ended Dec 31, 2025 |
| J0380 | Injection, metaraminol bitartrate, per 10 mg | — | Jan 1, 1982 | Ended Dec 31, 2025 |
| J0390 | Injection, chloroquine hydrochloride, up to 250 mg | — | Jan 1, 1986 | Active |
| J0391 | Injection, artesunate, 1 mg | — | Jan 1, 2024 | Active |
| J0395 | Injection, arbutamine hcl, 1 mg | — | Jan 1, 1999 | Ended Dec 31, 2025 |
| J0400 | Injection, aripiprazole, intramuscular, 0.25 mg | — | Jan 1, 2008 | Active |
| J0401 | Injection, aripiprazole (abilify maintena), 1 mg | $7.456per 1 MG | Jan 1, 2014 | Active |
| J0402 | Injection, aripiprazole (abilify asimtufii), 1 mg | $6.185per 1 MG | Jan 1, 2024 | Active |
| J0456 | Injection, azithromycin, 500 mg | $2.571per 500 MG | Jan 1, 2000 | Active |
| J0457 | Injection, aztreonam, 100 mg | $2.299per 100 MG | Jul 1, 2023 | Active |
| J0458 | Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg) | $1.756per 10 MG | Oct 1, 2025 | Active |
| J0461 | Injection, atropine sulfate, 0.01 mg | $0.104per 0.01 MG | Jan 1, 2010 | Active |
| J0462 | Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg | $0.129per 0.01 MG | Oct 1, 2025 | Active |
| J0463 | Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg | $0.020per 0.01 MG | Apr 1, 2026 | Active |
| J0470 | Injection, dimercaprol, per 100 mg | — | Jan 1, 1982 | Active |
| J0475 | Injection, baclofen, 10 mg | $186.996per 10 MG | Jan 1, 1994 | Active |
| J0476 | Injection, baclofen, 50 mcg for intrathecal trial | $46.539per 50 MCG | Jan 1, 1999 | Active |